Exploring your options for Mixed Connective Tissue Disease in India? Ginger Healthcare brings together a carefully chosen panel of reputed rheumatologists, practising at world-class hospitals accredited by JCI and NABH. Request a free opinion and a cost estimate from any doctor on the list, and our team will guide you through every step of your journey.
Here are the most reputed doctors in India for Mixed Connective Tissue Disease Treatment. Each specialist is carefully vetted for their expertise, experience, and patient outcomes.
Here are the most reputed hospitals in India for Mixed Connective Tissue Disease Treatment. These hospitals are known for advanced infrastructure, international accreditations, and high success rates.
Mixed connective tissue disease (MCTD) is a long-term systemic autoimmune condition in which the immune system mistakenly attacks the body's own connective tissues, producing symptoms that overlap with lupus, systemic sclerosis, and polymyositis. A hallmark of MCTD is the presence of high levels of anti-U1 RNP antibody in the blood. Common features include Raynaud's phenomenon, swollen puffy hands, joint pain and stiffness, muscle weakness, and fatigue; in more advanced cases the lungs, heart, kidneys, and digestive tract can be affected. There is no cure, but treatment — ranging from simple anti-inflammatory medications to potent immunosuppressants and targeted biologics — can control disease activity, protect organs, and allow most patients to lead full and active lives. Care is led by a rheumatologist, often with input from pulmonologists, cardiologists, and other specialists depending on which organs are involved.
Daily oral medications — anti-inflammatories, low-to-moderate dose steroids, and hydroxychloroquine — that reduce immune-system overactivity and relieve joint, skin, and mild systemic symptoms without major immunosuppression.
Estimated cost: ~$500 – $1,000
Typical tests: Anti-U1 RNP antibody titre, ANA with pattern (antinuclear antibody), Extended autoantibody panel (anti-dsDNA, anti-Sm, anti-Scl-70, anti-Jo-1), CBC, ESR, CRP, Kidney function (creatinine, eGFR) and urine microscopy, Liver function tests, Creatine kinase (CK) for muscle involvement, ECG and chest X-ray. Done in India before admission.
Estimated cost in India: $1,500 – $3,000
Treatment duration in India: ~2 weeks (~5 hospital visit days across the full span)
Disease-modifying drugs that dampen the overactive immune response more deeply than steroids alone, preserving organ function and allowing steroid doses to be reduced — used when first-line medications are insufficient.
Estimated cost: ~$1,000 – $1,500
Typical tests: Anti-U1 RNP antibody titre and extended autoantibody panel, CBC, ESR, CRP, LFT, KFT with urine protein, Creatine kinase (CK), High-resolution CT chest (HRCT) for interstitial lung disease screening, Pulmonary function tests (spirometry and DLCO), 2D Echocardiogram with Doppler for pulmonary artery pressure estimation, Nailfold capillaroscopy, ECG. Done in India before admission.
Estimated cost in India: $2,000 – $4,500
Treatment duration in India: ~3 weeks (~7 hospital visit days across the full span)
Intravenous biologic infusions that target specific immune cells responsible for autoantibody production, reserved for patients whose disease has not responded adequately to conventional DMARDs or who have serious organ-threatening involvement.
Estimated cost: ~$1,500 – $2,000
Typical tests: Anti-U1 RNP titre and extended autoantibody panel, CBC, ESR, CRP, LFT, KFT, urine protein, Creatine kinase (CK) and aldolase, High-resolution CT chest (HRCT), Pulmonary function tests (spirometry and DLCO), 2D Echocardiogram with Doppler, Hepatitis B, Hepatitis C, HIV serology (mandatory pre-biologic screen), Tuberculosis screening (Mantoux / IGRA), ECG and chest X-ray. Done in India before admission.
Estimated cost in India: $4,000 – $8,000
That works out to roughly $1,250 – $3,000 per cycle across 2 cycles, plus a one-time pre-treatment work-up of about ~$1,500 – $2,000 (done once). Per-cycle figures are approximate — the headline range above covers the full course.
Treatment duration in India: ~4 weeks (2 cycles × 14 days, ~10 hospital visit days)
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.